+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-vitro Toxicology Testing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 196 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5942518
The Global In-vitro Toxicology Testing Market is estimated to be USD 13.31 Bn in 2023 and is expected to reach USD 22.09 Bn by 2028 growing at a CAGR of 10.66%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global In-vitro Toxicology Testing Market is segmented based on Product & Service, Technology, Method, Toxicity Endpoint & Test, End-User Industry, and Geography.
  • By Product & Service, the market is classified into Consumables, Assays, Equipment, Software, and Services.
  • By Technology, the market is classified into Cell Culture, High-Throughput, and Toxicogenomics.
  • By Method, the market is classified into Biochemical Assay, Cellular Assay, Ex-Vivo, and In Silico.
  • By Toxicity Endpoint & Test, the market is classified into ADME (Absorption, Distribution, Metabolism, & Excretion), Skin Irritation, Corrosion, & Sensitization, Genotoxicity, Cytotoxicity, Ocular Toxicity Testing, Organ Toxicity, Phototoxicity, Dermal Toxicity, and Other Endpoints & Tests.
  • By End-User Industry, the market is classified into Chemicals, Household Products, Food & Beverages, and Pharmaceuticals & Cosmetic.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Aragen Life Sciences, Bio-Rad Laboratories, Inc., Eurofins Panlabs, Inc., GE Healthcare, Merck KGaA, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global In-vitro Toxicology Testing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global In-vitro Toxicology Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global In-vitro Toxicology Testing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Ethical Issues Pertaining to Animal Testing
4.1.2 Growing Acceptance of In-Vitro Toxicity Testing with the Evolution of 3D Cell Culture Systems
4.1.3 Extensive Adoption of In-Vitro Toxicology Assays attributed to Safety, Cost-Savings, and Time-Saving Parameters
4.2 Restraints
4.2.1 Lack of Standards to Establish Intricacies of In-Vivo Conditions
4.3 Opportunities
4.3.1 Rising Focus on Drug Discovery and Personalized Medicine
4.3.2 Growing Number of Toxicity Databases
4.4 Challenges
4.4.1 Dearth of Skilled Professionals in Toxicity Testing
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global In-vitro Toxicology Testing Market, By Product & Service
6.1 Introduction
6.2 Consumables
6.3 Assays
6.3.1 Bacterial Toxicity Assays
6.3.2 Enzyme Toxicity Assays
6.3.3 Cell-Based Elisa & Western Blots
6.3.4 Receptor-Binding Assays
6.3.5 Tissue Culture Assays
6.3.6 Other Assays
6.4 Equipment
6.5 Software
6.6 Services
7 Global In-vitro Toxicology Testing Market, By Technology
7.1 Introduction
7.2 Cell Culture
7.3 High-Throughput
7.4 Toxicogenomics
8 Global In-vitro Toxicology Testing Market, By Method
8.1 Introduction
8.2 Biochemical Assay
8.3 Cellular Assay
8.4 Ex-Vivo
8.5 In Silico
9 Global In-vitro Toxicology Testing Market, By Toxicity Endpoint & Test
9.1 Introduction
9.2 ADME (Absorption, Distribution, Metabolism, & Excretion)
9.3 Skin Irritation, Corrosion, & Sensitization
9.4 Genotoxicity
9.5 Cytotoxicity
9.6 Ocular Toxicity Testing
9.7 Organ Toxicity
9.8 Phototoxicity
9.9 Dermal Toxicity
9.10 Other Endpoints & Tests
10 Global In-vitro Toxicology Testing Market, By End-User Industry
10.1 Introduction
10.2 Chemicals
10.3 Household Products
10.4 Food & Beverages
10.5 Pharmaceuticals & Cosmetic
11 Americas’ In-vitro Toxicology Testing Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s In-vitro Toxicology Testing Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s In-vitro Toxicology Testing Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s In-vitro Toxicology Testing Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Abbott Laboratories
16.2 Aragen Life Sciences
16.3 Bio-Rad Laboratories, Inc.
16.4 BioIVT
16.5 Catalent, Inc.
16.6 Charles River
16.7 Creative Bioarray
16.8 Eurofins Panlabs, Inc.
16.9 Evotec
16.10 GE Healthcare
16.11 Gentronix Ltd.
16.12 HD Biosciences Co., Ltd.
16.13 InSphero
16.14 Laboratory Corporation of America Holdings
16.15 MB Research Laboratories
16.16 Merck KGaA
16.17 Promega Corp.
16.18 Quest Diagnostics Inc.
16.19 SGS SA
16.20 Thermo Fisher Scientific Inc.
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Aragen Life Sciences
  • Bio-Rad Laboratories, Inc.
  • BioIVT
  • Catalent, Inc.
  • Charles River
  • Creative Bioarray
  • Eurofins Panlabs, Inc.
  • Evotec
  • GE Healthcare
  • Gentronix Ltd.
  • HD Biosciences Co., Ltd.
  • InSphero
  • Laboratory Corporation of America Holdings
  • MB Research Laboratories
  • Merck KGaA
  • Promega Corp.
  • Quest Diagnostics Inc.
  • SGS SA
  • Thermo Fisher Scientific Inc.

Table Information